Temodal 250mg Capsule

About

Temodal 250mg Capsule contains temozolomide, an oral alkylating agent that is a cornerstone in the treatment of certain aggressive brain tumors, including newly diagnosed glioblastoma multiforme and refractory anaplastic astrocytoma. Temozolomide acts as a prodrug, undergoing rapid non-enzymatic hydrolysis at physiological pH to its active metabolite, MTIC (5-(3-methyl-1-triazen-1-yl)imidazole-4-carboxamide). MTIC then exerts its cytotoxic effects by methylating DNA at various sites, predominantly at the O6 and N7 positions of guanine. This DNA methylation leads to DNA damage, which subsequently triggers cell cycle arrest and programmed cell death (apoptosis) in rapidly dividing cancer cells. A key advantage of temozolomide is its ability to efficiently cross the blood-brain barrier, making it highly effective against central nervous system malignancies where many other chemotherapeutic agents fail to penetrate.

Uses

• Newly diagnosed glioblastoma multiforme
• Refractory anaplastic astrocytoma
• Other malignant gliomas
• Certain neuroendocrine tumors (off-label)

Directions For Use

Take orally on an empty stomach, preferably at bedtime, to minimize nausea. Swallow capsules whole with water.

Benefits

• Extends survival in glioblastoma patients
• Crosses the blood-brain barrier effectively
• Available in oral form for convenience
• Can be used in combination with radiotherapy
• Reduces tumor progression
• Improves disease-free survival

Side Effects

• Nausea
• Vomiting
• Fatigue
• Headache
• Constipation
• Myelosuppression (low blood counts)
• Hair loss (alopecia)
• Anorexia
• Rash
• Diarrhea
• Dizziness
• Opportunistic infections

Safety Measures

• Alcohol - Alcohol should be avoided or consumed minimally as it may worsen nausea, vomiting, and fatigue associated with treatment.
• Pregnancy - Temodal is teratogenic and contraindicated in pregnancy; women of childbearing potential must use effective contraception.
• Breastfeeding - Breastfeeding is not recommended during treatment and for a period after due to potential harm to the infant.
• Liver - Use with caution in patients with severe hepatic impairment; liver function should be monitored regularly.
• Kidney - No specific dose adjustment is typically required for mild to moderate renal impairment, but caution is advised in severe cases.
• Lung - Patients should be monitored for new or worsening respiratory symptoms, as rare cases of interstitial pneumonitis have been reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.